These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26231318)

  • 21. Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy.
    Zhou D; Shi T; Zhao S; Zhu J; Zhu L; Yang X; Xie W; Ye X
    J Clin Pharm Ther; 2020 Aug; 45(4):755-758. PubMed ID: 32403181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of clinical factors with thrombocytopenia in patients receiving linezolid treatment: a retrospective study.
    Thi Phuong Thao L; Duc Trung N; Thi My L; Minh Hong L; Viet Hoan B; Quang Hung V; Dang Hai P
    J Infect Dev Ctries; 2024 Feb; 18(2):285-290. PubMed ID: 38484357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
    Matsuo T; Wanaka K; Walenga JM
    Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between cytopenia and gestational age in infants and neonates treated with linezolid therapy.
    Shibata Y; Hagihara M; Kato H; Asai N; Koizumi Y; Watarai M; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2020 Jan; 26(1):95-100. PubMed ID: 31447138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia.
    Tanaka R; Suzuki Y; Morinaga Y; Iwao M; Takumi Y; Hashinaga K; Tatsuta R; Hiramatsu K; Kadota JI; Itoh H
    J Clin Pharm Ther; 2021 Apr; 46(2):343-351. PubMed ID: 33016566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma thrombopoietin level and platelet indices in hemodialysis patients receiving recombinant human erythropoietin.
    Asanuma M; Seino K; Mizuno T; Nasu M; Yamauchi F; Fujishima M
    Int J Lab Hematol; 2010 Jun; 32(3):312-9. PubMed ID: 19878361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-dilution haemodiafiltration and low-flux haemodialysis have dissimilar effects on platelets: a side study of CONTRAST.
    Gritters-van den Oever M; Grooteman MP; Bartels PC; Blankestijn PJ; Bots ML; van den Dorpel MA; Schoorl M; Schoorl M; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2009 Nov; 24(11):3461-8. PubMed ID: 19561150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid.
    Soriano A; Ortega M; García S; Peñarroja G; Bové A; Marcos M; Martínez JC; Martínez JA; Mensa J
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2559-63. PubMed ID: 17470658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days.
    Sato Y; Iguchi M; Kato Y; Morioka H; Hirabayashi A; Tetsuka N; Tomita Y; Kato D; Yamada K; Kimura H; Yagi T
    Nagoya J Med Sci; 2020 Aug; 82(3):407-414. PubMed ID: 33132425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.
    Lin SY; Huang JC; Shen MC; Chuang SH; Lee MH; Chen HC
    Hemodial Int; 2012 Oct; 16 Suppl 1():S50-3. PubMed ID: 23036037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
    Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
    J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
    Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR
    Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients.
    Cazavet J; Bounes FV; Ruiz S; Seguin T; Crognier L; Rouget A; Fourcade O; Minville V; Conil JM; Georges B
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):527-538. PubMed ID: 31853741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study.
    Cojutti PG; Merelli M; Bassetti M; Pea F
    J Antimicrob Chemother; 2019 Dec; 74(12):3588-3595. PubMed ID: 31504570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the risk factors of linezolid-related haematological toxicity in Chinese patients.
    Dai Y; Jiang S; Chen X; Han L; Zhang C; Yu X; Zhang X
    J Clin Pharm Ther; 2021 Jun; 46(3):807-813. PubMed ID: 33555057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.
    Tsuji Y; Holford NHG; Kasai H; Ogami C; Heo YA; Higashi Y; Mizoguchi A; To H; Yamamoto Y
    Br J Clin Pharmacol; 2017 Aug; 83(8):1758-1772. PubMed ID: 28186644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematologic effects of linezolid in young children.
    Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case-control study.
    Chen C; Li Y; Yu J; Qian S
    Clin Transl Oncol; 2022 Mar; 24(3):540-545. PubMed ID: 34716540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.